QQ客服 官方微博 反馈留言

	4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress
	Ma, Tianjiao; Zheng, Zongyu; Guo, Hua; Lian, Xin; Rane, Madhavi J.; Cai, Lu; Kim, Ki Soo; Kim, Kyoung Tae; Zhang, Zhiguo; Bi, Liqi
刊名	TOXICOLOGY AND APPLIED PHARMACOLOGY
	2019
卷号	370
关键词	4-O-Methylhonokiol Diabetic Nephropathy NE-kappa B AMPR Nrf2
ISSN号	0041-008X
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3534993
专题	吉林大学白求恩第一医院
推荐引用方式 GB/T 7714	Ma, Tianjiao,Zheng, Zongyu,Guo, Hua,et al. 4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY,2019,370.
APA	Ma, Tianjiao.,Zheng, Zongyu.,Guo, Hua.,Lian, Xin.,Rane, Madhavi J..,...&Bi, Liqi.(2019).4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.TOXICOLOGY AND APPLIED PHARMACOLOGY,370.
MLA	Ma, Tianjiao,et al."4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress".TOXICOLOGY AND APPLIED PHARMACOLOGY 370(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。